Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
4.82
0.37 (8.31%)
At close: Jun 02, 2025, 3:59 PM
4.80
-0.41%
Pre-market: Jun 03, 2025, 05:45 AM EDT
8.31% (1D)
| Bid | 4.55 |
| Market Cap | 429.67M |
| Revenue (ttm) | 59.61M |
| Net Income (ttm) | -181.01M |
| EPS (ttm) | -2.11 |
| PE Ratio (ttm) | -2.28 |
| Forward PE | -1.66 |
| Analyst | Strong Buy |
| Ask | 5 |
| Volume | 3,225,084 |
| Avg. Volume (20D) | 3,198,736 |
| Open | 4.54 |
| Previous Close | 4.45 |
| Day's Range | 4.50 - 5.10 |
| 52-Week Range | 2.87 - 9.30 |
| Beta | 1.68 |
About VERV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+3.61%
Verve Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+20.63%
Verve Therapeutics shares are trading higher after Canaccord Genuity raised its price target on the stock from $32 to $39 and maintained a Buy rating.
